Leqembi is an intravenous (IV) infusion therapy approved for treating early Alzheimer's disease
Leqembi is administered every two weeks via veinal infusion.
Patients must undergo regular MRI scans to check for potential side effects
Leqembi is an intravenous (IV) infusion therapy approved for treating early Alzheimer's disease
Leqembi is administered every two weeks via veinal infusion.
Patients must undergo regular MRI scans to check for potential side effects